Animal Health LatAm 2020 | Kisaco Research

Animal Health Innovation Latin America

Business Development & Partnering

View the Agenda
Virtual Event
18-20 August, 2020

“There is no other event in the region that offers so much knowledge sharing and networking opportunities”

Esteban Corrales, Director, Labyes

Why Attend

In this unprecedented and uncertain time, due to the rise of Covid-19 infections, there is a now a desperate need for greater collaboration and communication in the animal health sector. Strategic partnerships are vital  to deliver new solutions for the ‘Next Normal’ for the industry.

For Latin America, the situation is evolving. The region is one of the most important geographies for the production of animal protein and the 3rd largest market globally for animal health. With the global challenge of feeding another 2 billion people by 2050 still a top priority.

The region is also the 3rd largest market globally for pet care, with Brazil being home to over 58 million dogs and 27 million cats. Brazilian pet owners are keeping a separate budget for their pets and treating their pets as family members. This is part of a global humanization trend that is creating new business opportunities that continue even in this crisis.

At Kisaco Research we’re committed to giving the animal health community a platform where we can come together, continue to create vital strategic connections and drive deal making via virtual partnering meetings. We hope you will be able to join us online

 
200+
Attendees
50+
Start-ups
15+
1-to-1 Meetings per person

Speakers

 

Carlos Alberto Kuada

Vice President Latin America
Elanco Animal Health

Carlos Alberto Kuada

Vice President Latin America
Elanco Animal Health

Carlos Alberto Kuada

Vice President Latin America
Elanco Animal Health
 

Matias de Juan

Animal Health Business Unit Manager
Laboratorios Sanfer

Matias de Juan

Animal Health Business Unit Manager
Laboratorios Sanfer

Matias de Juan

Animal Health Business Unit Manager
Laboratorios Sanfer
 

Klaus Hellmann

CEO
Klifovet

Klaus Hellmann

CEO
Klifovet

Klaus Hellmann

CEO
Klifovet
 

Flávia De Marco Almeida

Intellectual Property Analyst - Biotechnology
CTIT UFMG

Flávia De Marco Almeida

Intellectual Property Analyst - Biotechnology
CTIT UFMG

Flávia De Marco Almeida

Intellectual Property Analyst - Biotechnology
CTIT UFMG
 

Luiz Luccas

Founder
ALPHA HLD

Luiz Luccas

Founder
ALPHA HLD

Luiz Luccas

Founder
ALPHA HLD
 

Delair Angelo Bolis

AVP - Brazil, Paraguay, Uruguay & Bolivia
MSD Animal Health

Delair Angelo Bolis

AVP - Brazil, Paraguay, Uruguay & Bolivia
MSD Animal Health

Delair Angelo Bolis

AVP - Brazil, Paraguay, Uruguay & Bolivia
MSD Animal Health
 

Luiz Xavier Royas

Senior Vice President and General Manager, Brazil
Zoetis Inc.

Luiz Xavier Royas

Senior Vice President and General Manager, Brazil
Zoetis Inc.

Luiz Xavier Royas

Senior Vice President and General Manager, Brazil
Zoetis Inc.
 

Marcio Waldman

CEO
Petlove

Marcio Waldman

CEO
Petlove

Marcio Waldman

CEO
Petlove
 

Felipe Cunha

CEO
Vetsmart

Felipe Cunha

CEO
Vetsmart

Felipe Cunha

CEO
Vetsmart
 

Felipe Diz

CEO
Zeedog

Felipe Diz

CEO
Zeedog

Felipe Diz

CEO
Zeedog
 

Mauricio Salvador

President
Brazilian E-commerce Association

Mauricio Salvador

President
Brazilian E-commerce Association

Mauricio Salvador

President
Brazilian E-commerce Association
 

Flavia Reis

Senior Director, Food Animal Research
Elanco Animal Health

Flavia Reis

Senior Director, Food Animal Research
Elanco Animal Health

Flavia Reis

Senior Director, Food Animal Research
Elanco Animal Health
 

Kristin Bloink

Vice President, Global Research & External Innovation
Elanco Animal Health

Kristin Bloink manages all internal discovery efforts and all external technology evaluations and subsequent portfolio entries for R&D.   She has 26 years of accomplishments in human clinical trials, animal drug discovery and development, translational model development and execution, and human and veterinary clinical medical delivery in the private as well as the military sector.  She joined Novartis Animal Health in 2007 and integrated into Elanco Animal Health in 2015.   

Kristin Bloink

Vice President, Global Research & External Innovation
Elanco Animal Health

Kristin Bloink

Vice President, Global Research & External Innovation
Elanco Animal Health

Kristin Bloink manages all internal discovery efforts and all external technology evaluations and subsequent portfolio entries for R&D.   She has 26 years of accomplishments in human clinical trials, animal drug discovery and development, translational model development and execution, and human and veterinary clinical medical delivery in the private as well as the military sector.  She joined Novartis Animal Health in 2007 and integrated into Elanco Animal Health in 2015.   

 

Kleber Gomes

CEO
Ourofino Saúde Animal

Kleber Gomes

CEO
Ourofino Saúde Animal

Kleber Gomes

CEO
Ourofino Saúde Animal
 

Byron Silva

Business and Regulatory Affairs Consultant
Vet Affairs Ltd

PROFILE:

- Veterinary with expertise for over 35 years in veterinary products segment working for local and global players. Previous experience in several areas of veterinary industry: vaccine production, QC, R&D, product manager, technical assistance and regulatory affairs.

- Support for technical and regulatory affairs for new and existing business.

- Support for development of new businesses in Brazil for global players.

Byron Silva

Business and Regulatory Affairs Consultant
Vet Affairs Ltd

Byron Silva

Business and Regulatory Affairs Consultant
Vet Affairs Ltd

PROFILE:

- Veterinary with expertise for over 35 years in veterinary products segment working for local and global players. Previous experience in several areas of veterinary industry: vaccine production, QC, R&D, product manager, technical assistance and regulatory affairs.

- Support for technical and regulatory affairs for new and existing business.

- Support for development of new businesses in Brazil for global players.

 

Maria Aparecida Melo Luspa, MSc.

Regional Technical Director- Brazil, Nutrition & Care
Evonik

Maria Aparecida Melo Luspa, MSc.

Regional Technical Director- Brazil, Nutrition & Care
Evonik

Maria Aparecida Melo Luspa, MSc.

Regional Technical Director- Brazil, Nutrition & Care
Evonik
 

Gustavo Osorio

Commercial Manager
Dechra Pharmaceuticals

Gustavo Osorio is a Mexican Veterinarian who started his successful career in the Animal Health Industry as sales representative for companion animal products with Pfizer Animal Health, where he gained commercial experience working with distributors and third party sales forces.

Gustavo Osorio

Commercial Manager
Dechra Pharmaceuticals

Gustavo Osorio

Commercial Manager
Dechra Pharmaceuticals

Gustavo Osorio is a Mexican Veterinarian who started his successful career in the Animal Health Industry as sales representative for companion animal products with Pfizer Animal Health, where he gained commercial experience working with distributors and third party sales forces.

During his tenure in Pfizer Animal Health, Gustavo held different position of increased responsibility. He worked as Technical Manager for Companion Animal being responsible for technical trainings for the team as well as speaker in different events. He was promoted to Sales Force Manager, working in a sales efficiency project while starting his incursion in marketing, this movement allowed him to move to the Marketing Manager position.

In 2006, Gustavo joined Bayer Animal Health as Marketing Manager for Companion Animals. During his 8 year tenure, he contributed to the evolution of the business unit by introducing new lines of products while managing the growth of the companion animals portfolio.

From 2014 to 2018, Gustavo was Influencer Marketing Manager for Eukanuba at Mars. This position allowed him to better understand the motivations and habits of pet owners as well as learn from the pet food industry and gain a new set of skills oriented at the commercial models applied in this segment.

 

Since 2018, Gustavo is the Commercial Manager for Mexico, Central America and the Caribbean at Dechra Brovel, the Mexican subsidiary of Dechra. He is focused on the transformation of the company structure from a family owned company to an international corporation, successfully launching specialized products such as Vetoryl and Zycortal while maintaining the growth of the generic products business. He is also developing and strengthening his team to address future challenges.

 

Kieran Gartlan

Managing Director
The Yieldlab

Kieran Gartlan

Managing Director
The Yieldlab

Kieran Gartlan

Managing Director
The Yieldlab
 

Angélica Patarroyo Vargas

Business and Partnerships
Fundação Arthur Bernardes (FUNARBE)

Angélica Patarroyo Vargas

Business and Partnerships
Fundação Arthur Bernardes (FUNARBE)

Angélica Patarroyo Vargas

Business and Partnerships
Fundação Arthur Bernardes (FUNARBE)
 

Arthur Gabriel da Silva

Strategic Alliances Analyst
CTIT UFMG

Arthur Gabriel da Silva

Strategic Alliances Analyst
CTIT UFMG

Arthur Gabriel da Silva

Strategic Alliances Analyst
CTIT UFMG
 

Bruna Nunes Marsiglio Sarout

Pesquisa Inovativa em Pequenas Empresas
FAPESP

Bruna Nunes Marsiglio Sarout

Pesquisa Inovativa em Pequenas Empresas
FAPESP

Bruna Nunes Marsiglio Sarout

Pesquisa Inovativa em Pequenas Empresas
FAPESP
 

Carla Berl

Director
VCA Inc.

Carla Berl

Director
VCA Inc.

Carla Berl

Director
VCA Inc.
 

Ricardo Nassar

Co Founder
Cobasi O shopping do seu animal

Ricardo Nassar has graduated in Business Administration by FAAP, an important University in Brazil. He is one of the  co-founder at Cobasi – o shopping do seu animal since 1885.

Together with his brothers, has created the concept of big pet shop in Brazil and has turned Cobasi into a reference in the Brazilian pet market. Cobasi is currently sales leader, with more 100 stores and e-commerce.

Ricardo Nassar

Co Founder
Cobasi O shopping do seu animal

Ricardo Nassar

Co Founder
Cobasi O shopping do seu animal

Ricardo Nassar has graduated in Business Administration by FAAP, an important University in Brazil. He is one of the  co-founder at Cobasi – o shopping do seu animal since 1885.

Together with his brothers, has created the concept of big pet shop in Brazil and has turned Cobasi into a reference in the Brazilian pet market. Cobasi is currently sales leader, with more 100 stores and e-commerce.

 

Prof. Newton C. Frateschi

Executive Director
Inova-UNICAMP: Unicamp Innovation Agency

Prof. Newton C. Frateschi is the Executive Director of the Inova-UNICAMP: Unicamp Innovation Agency. He was the director of the "Gleb Wataghin" Physics Institute (IFGW), University of Campinas – UNICAMP - Brazil from 2014 to 2017; the deputy director of this institute from 2010 to 2014. He was the director of the Center for Semiconductor Components and Nanotechnologies – UNICAMP from 2005 to 2010. From 2001 to 2003, he worked as a senior optoelectronic designer at T-Networks Inc., Pennsylvania, USA, in the advanced photonic device technology group.

Prof. Newton C. Frateschi

Executive Director
Inova-UNICAMP: Unicamp Innovation Agency

Prof. Newton C. Frateschi

Executive Director
Inova-UNICAMP: Unicamp Innovation Agency

Prof. Newton C. Frateschi is the Executive Director of the Inova-UNICAMP: Unicamp Innovation Agency. He was the director of the "Gleb Wataghin" Physics Institute (IFGW), University of Campinas – UNICAMP - Brazil from 2014 to 2017; the deputy director of this institute from 2010 to 2014. He was the director of the Center for Semiconductor Components and Nanotechnologies – UNICAMP from 2005 to 2010. From 2001 to 2003, he worked as a senior optoelectronic designer at T-Networks Inc., Pennsylvania, USA, in the advanced photonic device technology group. He obtained his Master’s and PhD in Electrical Engineering from the University of Southern California and his bachelor’s and Master’s degree in Physics from the IFGW - UNICAMP. He is a Brazilian National Research and Development Council (CNPq – Brasil) research fellow leading the device Research Laboratory (LPD – IFGW - UNICAMP) and the author and coauthor of over 100 scientific papers and several international patents primarily in the areas of optoelectronics and photonics.

 

Eduardo Carlos de Gosztonyi Abecia

Senior Director and General Manager
IDEXX Latin America

Eduardo Carlos de Gosztonyi Abecia

Senior Director and General Manager
IDEXX Latin America

Eduardo Carlos de Gosztonyi Abecia

Senior Director and General Manager
IDEXX Latin America
 

Clóvis De Oliveira

Head of Latin American Region
Boehringer Ingelheim Animal Health

Clóvis De Oliveira

Head of Latin American Region
Boehringer Ingelheim Animal Health

Clóvis De Oliveira

Head of Latin American Region
Boehringer Ingelheim Animal Health
 

Carla Freitas

Leader of Research and Development - Brazil
Zoetis

Carla Freitas

Leader of Research and Development - Brazil
Zoetis

Carla Freitas

Leader of Research and Development - Brazil
Zoetis

Who Attends?

Attendees from the Animal Health Latam series

Associate Partner

Platinum Digital Innovation Partners

Gold Digital Innovation Partner

Media Partners

The Agenda

You can download our agenda here.

Simply fill in this form and we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.

 

 

Download the Agenda

Global Advisory Board

Author:

Marc Prikazsky

Chairman and Chief Executive Officer
CEVA Santé Animale S.A

Author:

Mr. Rob Kelly

Executive Vice President International Operations
Zoetis Inc.

Author:

Aaron Schacht

Executive Vice President - Innovation, Regulatory & Business Development
Elanco

Mr. Aaron Schacht is currently the Vice President of Global Research and Development / Regulatory Affairs at Elanco Animal Health. Prior to this, Mr. Aaron Schacht held a role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache. In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up. Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.

Author:

Sébastien Huron

Chairman of the Executive Board
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.

Author:

Jean-Luc Michel

Head of Global Strategic Marketing
Boehringer Ingelheim

After graduating from the University of Pharmacy of Lyon with a Doctorate and from EM Lyon Business School with an MBA, Jean-Luc Michel started his career by creating his own consultancy company. He joined the pharmaceutical industry in 1991 spending 10 years developing a solid expertise in consumer healthcare and nutrition. During this period, he held a variety of senior marketing and sales management positions in France at Monsanto (Searle) and at Johnson&Johnson / Merck & Co where he was an Executive Committee member of the French subsidiary.

In 2001, Jean-Luc joined Merial, a leader in the animal health industry, where he held some key senior roles, such as EMEA Marketing Director of the Companion Animal Global Enterprise; Head of Marketing EMEA; Executive Marketing Director (Pet Business) in the US; VP, Head of Pet Vet Business Unit; and in 2016 joined the Executive Committee of Merial as Head of Global Commercial Development.

After the acquisition of Merial by Boehringer Ingelheim, Jean-Luc was appointed Head of Global Companion Animal Strategic Business Unit and became a member of the Executive Committee of the Boehringer Ingelheim Animal Health Business Unit.

Author:

Kathy V. Turner

Corporate Vice President and Global Chief Marketing Officer
IDEXX

Ms. Turner has been Corporate Vice President of IDEXX since May 2014 and leads the Company’s Europe, Middle East and Asia (EMEA) Companion Animal Commercial Operations. Prior to joining the Company, from 1987 to May 2014, Ms. Turner held various leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.

Author:

George Gunn

Founder and Partner
Stonehaven Consulting AG

Author:

Linda Rhodes

Independent Animal Health Expert

Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.

Author:

Alan Mackay

Executive Partner and Founder
GHO Capital

Alan has been a private equity investor for more than 25 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i Group plc. He was appointed to the board of 3i plc in 1993 and became CEO of 3i Nordic plc, based in Stockholm, upon the acquisition of Sweden's largest listed private equity company Atle AB in 2001. Alan has served on the boards of a number of healthcare companies, including most recently Phibro Animal Health Corporation which completed a successful initial public offering (IPO) in April 2014. Latterly he has been Managing Partner, CEO, and Chairman of the Investment Committee, of Hermes GPE, an active co-investor in private equity backed healthcare. Alan holds a Bachelor's degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He is Chair of the BVCA for 2016 – 2017 and previously chaired its Responsible Investment Advisory Board.

Author:

Dave Ross

Chief Executive Officer
Agri-EPI Centre Ltd

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Ticket prices increase in

Preparing registration...

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Press Partnerships

Whether you are an association, embassy, industry body or publication, we can offer a tailored marketing partnership to suit your needs. As a Media Partner we can:

  • Promote your organisation as an event partner across all conference materials, including the website, brochure, emails and on-site programme
  • Offer your members or readers a discount on their registration fee for Animal Health Investment Europe
  • Provide one free press pass to attend
  • Distribute promotional materials at the conference

If you are a registered industry journalist or member of the press and would like to arrange an interview with a speaker or to discuss the event please contact:

Jessica Parry
Senior Marketing Manager
T: +44 (0)203 696 2920
E: [email protected]

Venue

Virtual Event

This year's Animal Health Innovation LatAm will be a virtual event.

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Other events you might be interested in:

AH Europe 2021

Animal Health Asia 2020